Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1350060
European Journal of Endocrinology, Vol 135, Issue 1, 60-68
Copyright © 1996 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aust, G.
Right arrow Articles by Scherbaum, W. A
Right arrow Search for Related Content
PubMed
Right arrow Articles by Aust, G.
Right arrow Articles by Scherbaum, W. A

Activated and interferon-{gamma} producing thyroid-derived T cells are detected in Graves' disease, thyroid autonomy as well as in non-toxic multinodular goiter

Gabriela Aust, Irina Lehmann, Sandy Laue and Werner A Scherbaum

Aust G, Lehmann I, Laue S, Scherbaum WA. Activated and interferon-{gamma} producing thyroid-derived T cells are detected in Graves' disease, thyroid autonomy as well as in non-toxic multinodular goiter. Eur J Endocrinol 1996;135:60–8. ISSN 0804–4643

The relative numbers of activated and interferon gamma (IFN-{gamma})-producing peripheral blood lymphocytes (PBL) and thyroid-derived lymphocytes (TL) were determined using double surface and intracellular labeling techniques in flow cytometry. Cells were analyzed from 10 patients with Graves' disease (GD), eight patients with thyroid autonomy (TA) and five patients with non-toxic multinodular goiter (NTG). A maximum of 1% IFN-{gamma}+ cells were detected both in unstimulated PBL and TL. Stimulation caused a two- to threefold higher number of IFN-{gamma}+ cells in TL (GD, 48 ± 12%; TA, 48 ± 11%; NTG, 50± 15%) as compared to PBL (GD, 15 ± 7%: TA, 16 ± 8%; NTG, 18 ± 10%) of the same patients. Nearly all IFN-{gamma}+ TL in GD were CD3+ T cells, whereas 10–20% of IFN-{gamma}+ TL in TA and NTG were NK cells. In PBL 80% and in TL almost 100% of IFN-{gamma}+ cells were antigenprimed CD45RO+ cells. Only 25–35% of IFN-{gamma}+ thyroid-derived T cells expressed the CD4 antigen. About 42 ± 10% thyroid-derived T cells in GD, 33 ± 11% in TA and 34 ± 13% in NTG expressed the HLA-DR molecule but not the interleukin 2 (CD25) or the transferrin receptor (CD71). Forty per cent of these HLA-DR+ T cells showed an intracellular staining for IFN-{gamma} and half of them co-expressed the activation antigen CD69. Immunofluorescence double labeling on thyroid cryostat sections demonstrated that HLA-DR+ T cells were also present in situ. The presence of activation antigens on thyroid-derived T cells not only in patients with GD but also in TA and NTG suggests failsafe mechanisms such as anergy, suppression or cytokine regulation in so-called non-immunogenic goiter.

Gabriela Aust, Department of Internal Medicine III, Endocrinology, University of Leipzig, Ph.-Rosenthal-Str. 27, Leipzig, D-04103, Germany




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
G Aust, K Krohn, N G Morgenthaler, S Schroder, A Schutz, J Edelmann, and E Brylla
Graves' disease and Hashimoto's thyroiditis in monozygotic twins: case study as well as transcriptomic and immunohistological analysis of thyroid tissues
Eur. J. Endocrinol., January 1, 2006; 154(1): 13 - 20.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Aust, M. Steinert, S. Kiessling, M. Kamprad, and C. Simchen
Reduced Expression of Stromal-Derived Factor 1 in Autonomous Thyroid Adenomas and Its Regulation in Thyroid-Derived Cells
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3368 - 3376.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Simchen, I. Lehmann, D. Sittig, M. Steinert, and G. Aust
Expression and Regulation of Regulated on Activation, Normal T Cells Expressed and Secreted in Thyroid Tissue of Patients with Graves' Disease and Thyroid Autonomy and in Thyroid-Derived Cell Populations
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4758 - 4764.
[Abstract] [Full Text]


Home page
Postgrad. Med. J.Home page
M A Hasanat, M A K Rumi, M N Alam, K N. Hasan, M Salimullah, M A Salam, M Fariduddin, H. Mahtab, and A K A. Khan
Status of antithyroid antibodies in Bangladesh
Postgrad. Med. J., June 1, 2000; 76(896): 345 - 349.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. A. Ajjan, P. F. Watson, and A. P. Weetman
Detection of IL-12, IL-13, and IL-15 Messenger Ribonucleic Acid in the Thyroid of Patients with Autoimmune Thyroid Disease
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 666 - 669.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 European Society of Endocrinology.